截图来源:Lancet官网
参考资料(可上下滑动查看) [1] Brunner FJ, et al., (2019). Application of non-HDL cholesterol for population-based cardiovascular risk stratification: results from the Multinational Cardiovascular Risk Consortium. The Lancet, 10.1016/S0140-6736(19)32519-X. [2] Robinson JG, et al., (2019). The next treatment paradigm in cardiovascular prevention?. The Lancet, 10.1016/S0140-6736(19)32949-6. [3] Study: Lifetime Risk Matters in Lipid Management. Retrieved Dec 4, 2019, from https://www./cardiology/dyslipidemia/83673 [4] expert reaction to study estimating link between cholesterol levels and risk of heart disease and stroke. Retrieved Dec 4, 2019, from https://www./expert-reaction-to-study-estimating-link-between-cholesterol-levels-and-risk-of-heart-disease-and-stroke/ [5] 中国成人血脂异常防治指南(2016 年修订版) |
|